454 related articles for article (PubMed ID: 25499371)
1. Renal function largely influences Galectin-3 prognostic value in heart failure.
Zamora E; Lupón J; de Antonio M; Galán A; Domingo M; Urrutia A; Troya M; Bayes-Genis A
Int J Cardiol; 2014 Nov; 177(1):171-7. PubMed ID: 25499371
[TBL] [Abstract][Full Text] [Related]
2. Head-to-head comparison of 2 myocardial fibrosis biomarkers for long-term heart failure risk stratification: ST2 versus galectin-3.
Bayes-Genis A; de Antonio M; Vila J; Peñafiel J; Galán A; Barallat J; Zamora E; Urrutia A; Lupón J
J Am Coll Cardiol; 2014 Jan; 63(2):158-66. PubMed ID: 24076531
[TBL] [Abstract][Full Text] [Related]
3. Renal dysfunction in patients with heart failure with preserved versus reduced ejection fraction: impact of the new Chronic Kidney Disease-Epidemiology Collaboration Group formula.
McAlister FA; Ezekowitz J; Tarantini L; Squire I; Komajda M; Bayes-Genis A; Gotsman I; Whalley G; Earle N; Poppe KK; Doughty RN;
Circ Heart Fail; 2012 May; 5(3):309-14. PubMed ID: 22441773
[TBL] [Abstract][Full Text] [Related]
4. Renal function in heart failure: a disparity between estimating function and predicting mortality risk.
Plischke M; Neuhold S; Kohl M; Heinze G; Sunder-Plassmann G; Pacher R; Hülsmann M
Eur J Heart Fail; 2013 Jul; 15(7):763-70. PubMed ID: 23429976
[TBL] [Abstract][Full Text] [Related]
5. Long-term prognostic value for patients with chronic heart failure of estimated glomerular filtration rate calculated with the new CKD-EPI equations containing cystatin C.
Zamora E; Lupón J; de Antonio M; Vila J; Peñafiel J; Galán A; Urrutia A; Domingo M; Bayes-Genis A
Clin Chem; 2014 Mar; 60(3):481-9. PubMed ID: 24255081
[TBL] [Abstract][Full Text] [Related]
6. Galectin 3: association to neurohumoral activity, echocardiographic parameters and renal function in outpatients with heart failure.
Stoltze Gaborit F; Bosselmann H; Kistorp C; Iversen K; Kumler T; Gustafsson F; Goetze JP; Sölétormos G; Tønder N; Schou M
BMC Cardiovasc Disord; 2016 May; 16():117. PubMed ID: 27246703
[TBL] [Abstract][Full Text] [Related]
7. Relationship of plasma galectin-3 to renal function in patients with heart failure: effects of clinical status, pathophysiology of heart failure, and presence or absence of heart failure.
Gopal DM; Kommineni M; Ayalon N; Koelbl C; Ayalon R; Biolo A; Dember LM; Downing J; Siwik DA; Liang CS; Colucci WS
J Am Heart Assoc; 2012 Oct; 1(5):e000760. PubMed ID: 23316284
[TBL] [Abstract][Full Text] [Related]
8. The Chronic Kidney Disease Epidemiology Collaboration equation outperforms the Modification of Diet in Renal Disease equation for estimating glomerular filtration rate in chronic systolic heart failure.
Valente MA; Hillege HL; Navis G; Voors AA; Dunselman PH; van Veldhuisen DJ; Damman K
Eur J Heart Fail; 2014 Jan; 16(1):86-94. PubMed ID: 23901055
[TBL] [Abstract][Full Text] [Related]
9. Prognostic value of glomerular filtration rate estimation equations in acute heart failure with preserved versus reduced ejection fraction.
Casado Cerrada J; Carrasco Sánchez FJ; Pérez-Calvo JI; Manzano L; Formiga F; Aramburu Bodas O; Conde A; Quirós R; Pérez Bocanegra C; Montero-Pérez-Barquero M;
Int J Clin Pract; 2015 Aug; 69(8):829-39. PubMed ID: 25651522
[TBL] [Abstract][Full Text] [Related]
10. Prognostic value of renin and prorenin in heart failure patients with decreased kidney function.
Szymanski MK; Damman K; van Veldhuisen DJ; van Gilst WH; Hillege HL; de Boer RA
Am Heart J; 2011 Sep; 162(3):487-93. PubMed ID: 21884865
[TBL] [Abstract][Full Text] [Related]
11. Estimated glomerular filtration rate and prognosis in heart failure: value of the Modification of Diet in Renal Disease Study-4, chronic kidney disease epidemiology collaboration, and cockroft-gault formulas.
Zamora E; Lupón J; Vila J; Urrutia A; de Antonio M; Sanz H; Grau M; Ara J; Bayés-Genís A
J Am Coll Cardiol; 2012 May; 59(19):1709-15. PubMed ID: 22554602
[TBL] [Abstract][Full Text] [Related]
12. Use of cystatin C levels in estimating renal function and prognosis in patients with chronic systolic heart failure.
Damman K; van der Harst P; Smilde TD; Voors AA; Navis G; van Veldhuisen DJ; Hillege HL
Heart; 2012 Feb; 98(4):319-24. PubMed ID: 22038544
[TBL] [Abstract][Full Text] [Related]
13. Association of galectin-3 and fibrosis markers with long-term cardiovascular outcomes in patients with heart failure, left ventricular dysfunction, and dyssynchrony: insights from the CARE-HF (Cardiac Resynchronization in Heart Failure) trial.
Lopez-Andrès N; Rossignol P; Iraqi W; Fay R; Nuée J; Ghio S; Cleland JG; Zannad F; Lacolley P
Eur J Heart Fail; 2012 Jan; 14(1):74-81. PubMed ID: 22089058
[TBL] [Abstract][Full Text] [Related]
14. Sequential changes in renal function and the risk of stroke and death in patients with atrial fibrillation.
Guo Y; Wang H; Zhao X; Zhang Y; Zhang D; Ma J; Wang Y; Lip GY
Int J Cardiol; 2013 Oct; 168(5):4678-84. PubMed ID: 23972369
[TBL] [Abstract][Full Text] [Related]
15. Prognostic value of worsening renal function in outpatients with chronic heart failure.
Pimentel R; Couto M; Laszczyńska O; Friões F; Bettencourt P; Azevedo A
Eur J Intern Med; 2014 Sep; 25(7):662-8. PubMed ID: 24986374
[TBL] [Abstract][Full Text] [Related]
16. Prognostic Effect of Renal Function in Ambulatory Patients With Heart Failure and Reduced Ejection Fraction: The Kidney Is a Marker of Cardiac Function.
Mascarenhas J; Laszczynska O; Severo M; Friões F; Alvelos M; Bettencourt P; Pimenta J; Azevedo A
Can J Cardiol; 2018 Oct; 34(10):1325-1332. PubMed ID: 30201253
[TBL] [Abstract][Full Text] [Related]
17. Cystatin C in acute heart failure without advanced renal impairment.
Naruse H; Ishii J; Kawai T; Hattori K; Ishikawa M; Okumura M; Kan S; Nakano T; Matsui S; Nomura M; Hishida H; Ozaki Y
Am J Med; 2009 Jun; 122(6):566-73. PubMed ID: 19393984
[TBL] [Abstract][Full Text] [Related]
18. Usefulness of plasma galectin-3 levels in systolic heart failure to predict renal insufficiency and survival.
Tang WH; Shrestha K; Shao Z; Borowski AG; Troughton RW; Thomas JD; Klein AL
Am J Cardiol; 2011 Aug; 108(3):385-90. PubMed ID: 21600537
[TBL] [Abstract][Full Text] [Related]
19. Influence of renal impairment on myocardial function in outpatients with systolic heart failure: an echocardiographic and cardiac biomarker study.
Bosselmann H; Tonder N; Sölétormos G; Rossing K; Iversen K; Goetze JP; Gustafsson F; Schou M
Int J Cardiol; 2014 Dec; 177(3):942-8. PubMed ID: 25449505
[TBL] [Abstract][Full Text] [Related]
20. Influence of renal function on the use of guideline-recommended therapies for patients with heart failure.
Heywood JT; Fonarow GC; Yancy CW; Albert NM; Curtis AB; Stough WG; Gheorghiade M; McBride ML; Mehra MR; O'Connor CM; Reynolds D; Walsh MN
Am J Cardiol; 2010 Apr; 105(8):1140-6. PubMed ID: 20381667
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
